These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26081945)

  • 1. GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases.
    Stanca DM; Mărginean IC; Sorițău O; Dragoș C; Mărginean M; Mureșanu DF; Vester JC; Rafila A
    J Cell Mol Med; 2015 Sep; 19(9):2253-61. PubMed ID: 26081945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke.
    Dvorak F; Haberer I; Sitzer M; Foerch C
    Cerebrovasc Dis; 2009; 27(1):37-41. PubMed ID: 19018136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke.
    Foerch C; Curdt I; Yan B; Dvorak F; Hermans M; Berkefeld J; Raabe A; Neumann-Haefelin T; Steinmetz H; Sitzer M
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):181-4. PubMed ID: 16174653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Glial Fibrillary Acidic Protein in the Differential Diagnosis of Intracerebral Hemorrhage.
    Katsanos AH; Makris K; Stefani D; Koniari K; Gialouri E; Lelekis M; Chondrogianni M; Zompola C; Dardiotis E; Rizos I; Parissis J; Boutati E; Voumvourakis K; Tsivgoulis G
    Stroke; 2017 Sep; 48(9):2586-2588. PubMed ID: 28751552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage.
    Llombart V; García-Berrocoso T; Bustamante A; Giralt D; Rodriguez-Luna D; Muchada M; Penalba A; Boada C; Hernández-Guillamon M; Montaner J
    J Neurochem; 2016 Jan; 136(2):416-24. PubMed ID: 26526443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke.
    Foerch C; Niessner M; Back T; Bauerle M; De Marchis GM; Ferbert A; Grehl H; Hamann GF; Jacobs A; Kastrup A; Klimpe S; Palm F; Thomalla G; Worthmann H; Sitzer M;
    Clin Chem; 2012 Jan; 58(1):237-45. PubMed ID: 22125303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glial fibrillary acidic protein as a biomarker in differentiating intracerebral haemorrhage from ischaemic stroke and stroke mimics: a meta-analysis.
    Kumar A; Misra S; Yadav AK; Sagar R; Verma B; Grover A; Prasad K
    Biomarkers; 2020 Feb; 25(1):1-8. PubMed ID: 31702405
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of Blood Biomarkers in Differentiating Ischemic Stroke and Intracerebral Hemorrhage.
    Bhatia R; Warrier AR; Sreenivas V; Bali P; Sisodia P; Gupta A; Singh N; Padma Srivastava MV; Prasad K
    Neurol India; 2020; 68(4):824-829. PubMed ID: 32859821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial Fibrillary Acidic Protein Serum Levels Distinguish between Intracerebral Hemorrhage and Cerebral Ischemia in the Early Phase of Stroke.
    Luger S; Witsch J; Dietz A; Hamann GF; Minnerup J; Schneider H; Sitzer M; Wartenberg KE; Niessner M; Foerch C;
    Clin Chem; 2017 Jan; 63(1):377-385. PubMed ID: 27881450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum brain damage biomarkers as a diagnostic and prognostic tool in ischemic stroke].
    Chaykovskaya AD; Topuzova MP; Ternovykh IK; Makhanova AM; Mikheeva AG; Pospelova ML; Panina EB; Vavilova TV; Vasilieva EY; Shustova TA; Alekseeva TM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8. Vyp. 2):37-46. PubMed ID: 37682094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic potential of the NMDA receptor peptide assay for acute ischemic stroke.
    Dambinova SA; Bettermann K; Glynn T; Tews M; Olson D; Weissman JD; Sowell RL
    PLoS One; 2012; 7(7):e42362. PubMed ID: 22848761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating autoantibodies against the NR2 peptide of the NMDA receptor are associated with subclinical brain damage in hypertensive patients with other pre-existing conditions for vascular risk.
    González-García S; González-Quevedo A; Hernandez-Diaz Z; Alvarez Camino L; Peña-Sanchez M; Cordero-Eiriz A; Brown M; Gaya JA; Betancourt-Losa M; Fernandez-Almirall I; Menendez-Sainz MC; Fernandez-Carriera R
    J Neurol Sci; 2017 Apr; 375():324-330. PubMed ID: 28320161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome.
    Larsson IM; Wallin E; Kristofferzon ML; Niessner M; Zetterberg H; Rubertsson S
    Resuscitation; 2014 Dec; 85(12):1654-61. PubMed ID: 25260722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocytes carrying GFAP detect glioma, brain metastasis and ischaemic stroke, and predict glioblastoma survival.
    van den Bossche WBL; Vincent AJPE; Teodosio C; Koets J; Taha A; Kleijn A; de Bruin S; Dik WA; Damasceno D; Almeida J; Dippel DWJ; Dirven CMF; Orfao A; Lamfers MLM; van Dongen JJM;
    Brain Commun; 2021; 3(1):fcaa215. PubMed ID: 33501422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Reactive Antibodies against the N-Methyl-D-Aspartate Receptor NR2 Subunit-Could They Act as Potential Biomarkers?
    Hadjiagapiou MS; Krashias G; Christodoulou C; Pantzaris M; Lambrianides A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients.
    Ren C; Kobeissy F; Alawieh A; Li N; Li N; Zibara K; Zoltewicz S; Guingab-Cagmat J; Larner SF; Ding Y; Hayes RL; Ji X; Mondello S
    Sci Rep; 2016 Apr; 6():24588. PubMed ID: 27074724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum.
    Vissers JL; Mersch ME; Rosmalen CF; van Heumen MJ; van Geel WJ; Lamers KJ; Rosmalen FM; Swinkels LM; Thomsen J; Herrmann M
    Clin Chim Acta; 2006 Apr; 366(1-2):336-40. PubMed ID: 16405937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glial fibrillary acidic protein in patients with symptoms of acute stroke: diagnostic marker of cerebral hemorrhage].
    Foerch C; Pfeilschifter W; Zeiner P; Brunkhorst R
    Nervenarzt; 2014 Aug; 85(8):982-9. PubMed ID: 25057113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum glial fibrillary acidic protein as a biomarker for differentiating intracerebral hemorrhage and ischemic stroke in patients with symptoms of acute stroke: a systematic review and meta-analysis.
    Zhang J; Zhang CH; Lin XL; Zhang Q; Wang J; Shi SL
    Neurol Sci; 2013 Nov; 34(11):1887-92. PubMed ID: 24036689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: Systematic review and meta-analysis of diagnostic test accuracy.
    Perry LA; Lucarelli T; Penny-Dimri JC; McInnes MD; Mondello S; Bustamante A; Montaner J; Foerch C; Kwan P; Davis S; Yan B
    Int J Stroke; 2019 Jun; 14(4):390-399. PubMed ID: 30303809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.